Otonomy to Present at the Bank of America Merrill Lynch Health Care Conference
10 mai 2017 16h05 HE
|
Otonomy, Inc.
SAN DIEGO, May 10, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and...
Otonomy Reports First Quarter 2017 Financial Results and Provides Corporate Update
04 mai 2017 16h27 HE
|
Otonomy, Inc.
SAN DIEGO, May 04, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and...
Otonomy to Report First Quarter 2017 Financial Results and Provide Corporate Update
27 avr. 2017 16h05 HE
|
Otonomy, Inc.
SAN DIEGO, April 27, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
Otonomy Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
02 mars 2017 16h18 HE
|
Otonomy, Inc.
Topline data for OTO-104 Phase 3 trials in Ménière’s disease expected in 2H2017 Implemented changes to commercial organization to improve OTIPRIO® sales performance Company to host conference call...
Otonomy to Present at Cowen and Company Health Care Conference
28 févr. 2017 16h05 HE
|
Otonomy, Inc.
SAN DIEGO, Feb. 28, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
Otonomy Initiates Patient Enrollment in Phase 2 Clinical Trial of OTO-104 as Protectant Against Cisplatin-Induced Hearing Loss
19 janv. 2017 07h30 HE
|
Otonomy, Inc.
SAN DIEGO, Jan. 19, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
Otonomy Provides Corporate and Product Pipeline Update
09 janv. 2017 07h30 HE
|
Otonomy, Inc.
SAN DIEGO, Jan. 09, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
Otonomy to Present at the J.P. Morgan Healthcare Conference
03 janv. 2017 07h30 HE
|
Otonomy, Inc.
SAN DIEGO, Jan. 03, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
Otonomy Appoints Kathie M. Bishop, Ph.D., as Chief Scientific Officer
30 nov. 2016 07h30 HE
|
Otonomy, Inc.
SAN DIEGO, Nov. 30, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
Otonomy to Present at Piper Jaffray Healthcare Conference
22 nov. 2016 16h05 HE
|
Otonomy, Inc.
SAN DIEGO, Nov. 22, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...